Evidence map›Paper›PMID 40697167›Full record

ArticleEuropean journal of translational myology2025

Regenerative response of rat skeletal muscle to the implantation of a collagen-based bone graft substitute: an

Fernando Leiva-Cepas, Maria Jesus Gil-Belmonte, Ignacio Jimena, Maria Angeles Peña-Toledo, Rafael Villalba, Jose Peña-Amaro

Abstract read
In one paragraph

Article in European journal of translational myology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fernando Leiva-CepasResearch Group in Muscle Regeneration, Department of Morphological and Sociosanitary Sciences, Faculty of Medicine and Nursing, University of Cordoba, Cordoba, Spain; Maimonides Institute for Biomedical Research IMIBIC, Reina Sofia University Hospital, University of Cordoba, Spain; Department of Pathology, Reina Sofia University Hospital, Cordoba.ORCID 0000-0002-0014-3816
Maria Jesus Gil-BelmonteResearch Group in Muscle Regeneration, Department of Morphological and Sociosanitary Sciences, Faculty of Medicine and Nursing, University of Cordoba, Cordoba, Spain; Department of Pathology, Torrecardenas University Hospital, Almeria.ORCID 0000-0002-1088-6576
Ignacio JimenaResearch Group in Muscle Regeneration, Department of Morphological and Sociosanitary Sciences, Faculty of Medicine and Nursing, University of Cordoba, Cordoba, Spain; Maimonides Institute for Biomedical Research IMIBIC, Reina Sofia University Hospital, University of Cordoba.ORCID 0000-0002-5095-6962
Maria Angeles Peña-ToledoResearch Group in Muscle Regeneration, Department of Morphological and Sociosanitary Sciences, Faculty of Medicine and Nursing, University of Cordoba, Cordoba, Spain; Maimonides Institute for Biomedical Research IMIBIC, Reina Sofia University Hospital, University of Cordoba, Spain; Dementia and Multiple Sclerosis Unit, Neurology Service, Reina Sofia University Hospital, Cordoba.ORCID 0000-0002-9388-5893
Rafael VillalbaMaimonides Institute for Biomedical Research IMIBIC, Reina Sofia University Hospital, University of Cordoba, Spain; Tissue of Establishment of the Center for Transfusion, Tissues and Cells, Cordoba.ORCID 0000-0001-5600-3276
Jose Peña-AmaroResearch Group in Muscle Regeneration, Department of Morphological and Sociosanitary Sciences, Faculty of Medicine and Nursing, University of Cordoba, Cordoba, Spain; Maimonides Institute for Biomedical Research IMIBIC, Reina Sofia University Hospital, University of Cordoba.ORCID 0000-0002-2637-1112

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The application of implantable biomaterials in reconstructive grafting is a common practice in surgical fields such as orthopedics, maxillary and plastic surgery. This study explores the regenerative response of skeletal muscle to a porous bovine collagen-based matrix (Osteovit®) in a volumetric muscle loss injury model. Forty male Wistar rats were divided into four groups. Normal control underwent no procedure and regenerative control had mepivacaine injected in the tibialis anterior muscle to provoke a standard regenerative response. In the other two groups, a volumetric defect was created in the tibialis anterior muscle; the fibrosis control had no treatment, while the collagen-scaffolding group had a bone substitution matrix implanted. Animals were sacrificed at 21, 28, and 60 days post-procedure for histological, histochemical, immunohistochemical and histomorphometry analysis to evaluate muscle architecture and myogenic regenerative response. Significant changes in tissue architecture among groups, with a notable emphasis on the integration of the collagen scaffold, were demonstrated. This was also confirmed at the histomorphometry analysis, which found differences at the cross-sectional area, minor diameter and form factor values between groups The bone substitution matrix did not inhibit regeneration but promoted an abnormal one. This can be explained by the excessive formation of connective tissue, which led to the genesis of intramuscular tendons that may have interfered with the normal development of regenerative muscle fibers. The findings highlight the need for further investigation into the cellular mechanisms underlying skeletal muscle regeneration in response to implantable biomaterials.

Indexed as

bone substitutecollagen matrix scaffoldfibrosismuscle regenerationSkeletal musclevolumetric muscle loss

Identifiers

PMID40697167
PMCPMC12801115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.